Skip to main content
SpringerLink
Log in
Book cover

Probiotic Bacteria and Enteric Infections pp 429–443Cite as

Designer Probiotics and Enteric Cytoprotection

  • Chapter
  • First Online:

  • 1917 Accesses

Abstract

Binding of bacterial toxins or adhesins to oligosaccharide receptors on the surface of eukaryotic cells is a crucial step in the pathogenesis of many infectious diseases. Thus, blockade of such interactions is a promising anti-infective strategy. This can be achieved by engineering expression of molecular mimics of host oligosaccharides on the surface of probiotic bacteria. The outer core region of the lipopolysaccharide (LPS) of harmless Gram-negative bacteria, for example, can be manipulated by expression of cloned heterologous glycosyltransferases. The resultant chimeric LPS molecules are incorporated into the outer membrane by the normal assembly route, and are presented as a closely packed 2-D array of receptor mimics, capable of forming multivalent, high-avidity interactions with their cognate ligands. For enteric infections, oral administration of such receptor-mimic probiotics will bind and neutralize toxins in the gut lumen, or interfere with adherence of pathogens to the intestinal epithelium, thereby preventing disease.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Angstrom J, Teneberg S, Karlsson KA (1994) Delineation and comparison of ganglioside-binding epitopes for the toxins of Vibrio cholerae, Escherichia coli, and Clostridium tetani: evidence for overlapping epitopes. Proc Natl Acad Sci U S A 91:11859–11863

    Article  PubMed  CAS  Google Scholar 

  • Angstrom J, Bäckström M, Berntsson A, Karlsson N, Holmgren J, Karlsson KA, Lebens M, Teneberg S (2000) Novel carbohydrate binding site recognizing blood group A and B determinants in a hybrid of cholera toxin and Escherichia coli heat-labile enterotoxin B-subunits. J Biol Chem 275:3231–3238

    Article  PubMed  CAS  Google Scholar 

  • Banerjee P, Merkel GJ, Bhunia AK (2009) Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells. Gut Pathog 1(1):8

    Article  PubMed  Google Scholar 

  • Bovin NV, Tuzikov AB, Chinarev AA, Gambaryan AS (2004) Multimeric glycotherapeutics: new paradigm. Glycoconj J 21:471–478

    Article  PubMed  CAS  Google Scholar 

  • Byres E, Paton AW, Paton JC, Löfling JC, Smith DF, Wilce MCJ, Talbot UM, Chong DC, Yu H, Huang S, Chen X, Varki NM, Varki A, Rossjohn J, Beddoe T (2008) Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin. Nature 456:648–652

    Article  PubMed  CAS  Google Scholar 

  • Carey CM, Kostrzynska M, Ojha S, Thompson S (2008) The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. J Microbiol Methods 73:125–132

    Article  PubMed  CAS  Google Scholar 

  • DeGrandis S, Law H, Brunton J, Gyles C, Lingwood CA (1989) Globotetraosylceramide is recognized by the pig edema disease toxin. J Biol Chem 264:12520–12525

    Google Scholar 

  • Faridmoayer A, Fentabil MA, Haurat MF, Yi W, Woodward R, Wang PG, Feldman MF (2008) Extreme substrate promiscuity of the Neisseria oligosaccharyl transferase involved in protein O-glycosylation. J Biol Chem 283:34596–34604

    Article  PubMed  CAS  Google Scholar 

  • Feldman MF, Wacker M, Hernandez M, Hitchen PG, Marolda CL, Kowarik M, Morris HR, Dell A, Valvano MA, Aebi M (2005) Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli. Proc Natl Acad Sci U S A 102:3016–3021

    Article  PubMed  CAS  Google Scholar 

  • Focareta A, Paton JC, Morona R, Cook J, Paton AW (2006) A recombinant probiotic for treatment and prevention of cholera. Gastroenterology 130:1688–1695

    Article  PubMed  CAS  Google Scholar 

  • Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW (2002) The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem 277:327–337

    Article  PubMed  CAS  Google Scholar 

  • Godschalk PC, Kuijf ML, Li J, St Michael F, Ang CW, Jacobs BC, Karwaski MF, Brochu D, Moterassed A, Endtz HP, van Belkum A, Gilbert M (2007) Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infect Immun 75:1245–1254

    Article  PubMed  CAS  Google Scholar 

  • Guerry P, Szymanski CM (2008) Camplylobacter sugars sticking out. Trends Microbiol 16:428–435

    Article  PubMed  CAS  Google Scholar 

  • Heinrichs DE, Yethon JA, Amor PA, Whitfield C (1998) The assembly system for the outer core portion of R1- and R4-type lipopolysaccharides of Escherichia coli. J Biol Chem 273:29497–29505

    Article  PubMed  CAS  Google Scholar 

  • Hughes R (2004) Campylobacter jejuni in Guillain-Barré syndrome. Lancet Neurol 3:644

    Article  PubMed  Google Scholar 

  • Karlsson K (1998) Meaning and therapeutic potential of microbial recognition of host glycoconjugates. Mol Microbiol 19:1–11

    Article  Google Scholar 

  • Kitov PI, Sadowska JM, Mulvey G, Armstrong GD, Ling H, Pannu NS, Read RJ, Bundle DR (2000) Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature 403:669–672

    Article  PubMed  CAS  Google Scholar 

  • Linton D, Gilbert M, Hitchen PG, Dell A, Morris HR, Wakarchuk WW, Gregson NA, Wren BW (2000) Phase variation of a β-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni. Mol Microbiol 37:501–514

    Article  PubMed  CAS  Google Scholar 

  • Lyras D, O’Connor JR, Howarth PM, Sambol SP, Carter GP, Phumoonna T, Poon R, Adams V, Vedantam G, Johnson S, Gerding DN, Rood JI (2009) Toxin B is essential for virulence of Clostridium difficile. Nature 458:1176–1179

    Article  PubMed  CAS  Google Scholar 

  • Medellin-Peña MJ, Wang H, Johnson R, Anand S, Griffiths MW (2007) Probiotics affect virulence-related gene expression in Escherichia coli O157:H7. Appl Environ Microbiol 73:4259–4267

    Article  PubMed  Google Scholar 

  • Merritt EA, Zhang Z, Pickens JC, Ahn M, Hol WG, Fan E (2002) Characterization and crystal structure of a high-affinity pentavalent receptor-binding inhibitor for cholera toxin and E. coli heat labile enterotoxin. J Am Chem Soc 124:8818–8824

    Article  PubMed  CAS  Google Scholar 

  • Moran AP, Prendergast MM, Appelmelk BJ (1996) Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol Med Microbiol 16:105–115

    Article  PubMed  CAS  Google Scholar 

  • Mulvey G, Kitov PI, Marcato P, Bundle DR, Armstrong GD (2001) Glycan mimicry as a basis for anti-infective drugs. Biochimie 83:841–847

    Article  CAS  Google Scholar 

  • Nachamkin I, Liu J, Li M, Ung H, Moran AP, Prendergast MM, Sheikh K (2002) Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope. Infect Immun 70:5299–5303

    Article  PubMed  CAS  Google Scholar 

  • Nandi A, Mathew R, Visweswariah SS (1996) Expression of the extracellular domain of the human heat-stable enterotoxin receptor in Escherichia coli and generation of neutralizing antibodies. Protein Expr Purif 15:271–281

    Google Scholar 

  • Nataro JP, Kaper JB (1998) Diarrhoeagenic Escherichia coli. Clin Microbiol Rev 11:142–201

    PubMed  CAS  Google Scholar 

  • Newburg DS (2009) Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci 87(Suppl 1):26–34

    Article  PubMed  CAS  Google Scholar 

  • Parkes GC, Sanderson JD, Whelan K (2009) The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea. Lancet Infect Dis 9:237–244

    Article  PubMed  Google Scholar 

  • Paton JC, Paton AW (1998) Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 11:450–479

    PubMed  CAS  Google Scholar 

  • Paton AW, Ratcliff R, Doyle RM, Seymour-Murray J, Davos D, Lanser JA, Paton JC (1996) Molecular microbiological investigation of an outbreak of hemolytic uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli. J Clin Microbiol 34:1622–1627

    PubMed  CAS  Google Scholar 

  • Paton AW, Morona R, Paton JC (2000) A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans. Nature Med 6:265–270

    Article  PubMed  CAS  Google Scholar 

  • Paton AW, Morona R, Paton JC (2001a) Neutralization of Shiga toxins Stx1, Stx2c and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose. Infect Immun 69:1967–1970

    Article  CAS  Google Scholar 

  • Paton JC, Rogers TJ, Morona R, Paton AW (2001b) Oral administration of formalin-killed recombinant bacteria expressing a mimic of the Shiga toxin receptor protects mice from fatal challenge with Shiga toxigenic Escherichia coli. Infect Immun 69:1389–1393

    Article  CAS  Google Scholar 

  • Paton AW, Srimanote P, Talbot UM, Wang H, Paton JC (2004) A new family of potent AB5 cytotoxins produced by Shiga toxigenic Escherichia coli. J Exp Med 200:35–46

    Article  PubMed  CAS  Google Scholar 

  • Paton AW, Jennings MP, Morona R, Focareta A, Roddam LF, Paton JC (2005) Recombinant probiotics for treatment and prevention of travellers’ diarrhoea. Gastroenterology 128:1219–1228

    Article  PubMed  CAS  Google Scholar 

  • Paton AW, Morona R, Paton JC (2006a) Designer probiotics for prevention of enteric infections. Nature Rev Microbiol 4:193–200

    Article  CAS  Google Scholar 

  • Paton AW, Beddoe T, Thorpe CM, Whisstock JC, Wilce MCJ, Rossjohn J, Talbot UM, Paton JC (2006b) AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP. Nature 443:548–552

    Article  CAS  Google Scholar 

  • Pinyon RA, Paton JC, Paton AW, Botten JA, Morona R (2004) Refinement of a therapeutic Shiga toxin-binding probiotic for human trials. J Infect Dis 189:1547–1555

    Article  PubMed  CAS  Google Scholar 

  • Power PM, Roddam LF, Rutter K, Fitzpatrick SZ, Srikhanta YN, Jennings MP (2003) Genetic characterization of pilin glycosylation and phase variation in Neisseria meningitidis. Mol Microbiol 49:833–847

    Article  PubMed  CAS  Google Scholar 

  • Prendergast MM, Moran AP (2000) Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies. J Endotoxin Res 6:341–359

    PubMed  CAS  Google Scholar 

  • Raetz CR, Whitfield C (2002) Lipoploysaccharide endotoxins. Ann Rev Biochem 71:635–700

    Article  PubMed  CAS  Google Scholar 

  • Reissbrodt R, Hammes WP, dal Bello F, Prager R, Fruth A, Hantke K, Rakin A, Starcic-Erjavec M, Williams PH (2009) Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli. FEMS Microbiol Lett 290:62–69

    Article  PubMed  CAS  Google Scholar 

  • Ryan KA, O’Hara AM, van Pijkeren JP, Douillard FP, O’Toole PW (2009) Lactobacillus salivarius modulates cytokine induction and virulence factor gene expression in Helicobacter pylori. J Med Microbiol 58:996–1005

    Article  PubMed  CAS  Google Scholar 

  • Sack DA, Sack RB, Nair GB, Siddique AK (2004) Cholera. Lancet 363:223–233

    Article  CAS  Google Scholar 

  • Schengrund C-L (2003) “Multivalent” saccharides: development of new approaches for inhibiting the effects of glycosphingolipid-binding pathogens. Biochem Pharmacol 65:699–707

    Article  PubMed  CAS  Google Scholar 

  • Setia A, Bhandari SK, House JD, Nyachoti CM, Krause DO (2009) Development and in vitro evaluation of an Escherichia coli probiotic able to inhibit the growth of pathogenic Escherichia coli K88. J Anim Sci 87:2005–2012

    Article  PubMed  CAS  Google Scholar 

  • Tien MT, Girardin SE, Regnault B, Le Bourhis L, Dillies MA, Coppée JY, Bourdet-Sicard R, Sansonetti PJ, Pédron T (2006) Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 176:1228–1237

    PubMed  CAS  Google Scholar 

  • Vaandrager AB (2002) Structure and function of the heat-stable enterotoxin receptor/guanylyl cyclase C. Mol Cell Biochem 230:73–83

    Article  PubMed  CAS  Google Scholar 

  • Voth DE, Ballard JD (2005) Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18:247–263

    Article  PubMed  CAS  Google Scholar 

  • Wacker M, Feldman MF, Callewaert N, Kowarik M, Clarke BR, Pohl NL, Hernandez M, Vines ED, Valvano MA, Whitfield C, Aebi M (2006) Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems. Proc Natl Acad Sci U S A 103:7088–7093

    Article  PubMed  CAS  Google Scholar 

  • Wang H, Paton JC, Paton AW (2007) Pathologic changes in mice induced by subtilase cytotoxin, a potent new Escherichia coli AB5 toxin that targets the endoplasmic reticulum. J Infect Dis 196:1093–1101

    Article  PubMed  CAS  Google Scholar 

  • Willison HJ, Yuki N (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125:2591–2625

    Article  PubMed  Google Scholar 

  • Wolfson J, Thorpe CM, May KL, Paton JC, Jandhyala DM, Paton AW (2008) Subtilase cytotoxin activates PERK, ATF6 and IRE1 endoplasmic reticulum stress-signaling pathways. Cell Microbiol 10:1775–1786

    Article  PubMed  CAS  Google Scholar 

  • Yang Q-L, Gotschlich EC (1996) Variation of gonococcal lipooligosaccharide structure is due to alterations in poly-G tracts in lgt genes encoding glycosyl transferases. J Exp Med 183:323–327

    Article  PubMed  CAS  Google Scholar 

  • Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M (2004) Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci U S A 101:11404–11409

    Article  PubMed  CAS  Google Scholar 

  • Zopf D, Roth S (1996) Oligosaccharide anti-infective agents. Lancet 347:1017–1021

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Centre for Infectious Diseases, School of Molecular and Biomedical Science, University of Adelaide, 5005, Adelaide, SA, Australia

    Adrienne W. Paton, Renato Morona & James C. Paton

Authors
  1. Adrienne W. Paton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Renato Morona
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James C. Paton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adrienne W. Paton .

Editor information

Editors and Affiliations

  1. Faculty of Veterinary Medicine, Department of Veterinary Pathology, Sokoine University of Agriculture, Chuo Kikuu, Morogoro, Tanzania

    J.J. Malago

  2. Division Pathology, Dept of Pathobiology, Utrecht University, Yalelaan 1, Utrecht, 3508 TD, Netherlands

    J.F.J.G. Koninkx

  3. Biotechnical Faculty, Zootechnical Department, University of Ljubljana, Domžale, 1230, Slovenia

    R. Marinsek-Logar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Paton, A.W., Morona, R., Paton, J.C. (2011). Designer Probiotics and Enteric Cytoprotection. In: Malago, J., Koninkx, J., Marinsek-Logar, R. (eds) Probiotic Bacteria and Enteric Infections. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0386-5_18

Download citation

Publish with us

Policies and ethics

Search

Navigation